BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25686685)

  • 1. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
    ; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
    AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment.
    Bernal E; Gómez JM; Jarrín I; Cano A; Muñoz A; Alcaraz A; Imaz A; Iribarren JA; Rivero M; Arazo P; Gutiérrez F;
    J Acquir Immune Defic Syndr; 2018 Jul; 78(3):329-337. PubMed ID: 29543636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
    Gaifer Z; Boulassel MR
    J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
    Elvstam O; Medstrand P; Yilmaz A; Isberg PE; Gisslén M; Björkman P
    PLoS One; 2017; 12(7):e0180761. PubMed ID: 28683128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
    Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
    Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
    HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study.
    Ding H; Xu J; Liu J; Wang Q; Kang J; Li X; Zhang Z; Han X; Jiang Y; Geng W; Shang H
    HIV Med; 2022 Mar; 23 Suppl 1():64-71. PubMed ID: 35293103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana.
    Bareng OT; Moyo S; Mudanga M; Sebina K; Koofhethile CK; Choga WT; Moraka NO; Maruapula D; Gobe I; Motswaledi MS; Musonda R; Nkomo B; Ramaabya D; Chebani T; Makuruetsa P; Makhema J; Shapiro R; Lockman S; Gaseitsiwe S
    Viruses; 2024 May; 16(5):. PubMed ID: 38793602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
    Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
    HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Sungkanuparph S; Groger RK; Overton ET; Fraser VJ; Powderly WG
    HIV Med; 2006 Oct; 7(7):437-41. PubMed ID: 16925729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.
    Maggiolo F; Callegaro A; Cologni G; Bernardini C; Velenti D; Gregis G; Quinzan G; Soavi L; Iannotti N; Malfatto E; Leone S
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):473-82. PubMed ID: 22481602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.
    Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):999-1008. PubMed ID: 26165150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    Fleming J; Mathews WC; Rutstein RM; Aberg J; Somboonwit C; Cheever LW; Berry SA; Gebo KA; Moore RD;
    AIDS; 2019 Nov; 33(13):2005-2012. PubMed ID: 31306175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
    Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
    Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
    Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study.
    Yu H; Yang Y; Cao D; Zhao Y; Jin C; Sun H; Cao Y; Ye R; Yao S; Duan S; Wu Z
    HIV Med; 2023 Jan; 24(1):37-45. PubMed ID: 35578387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
    Zaccarelli M; Lorenzini P; Tozzi V; Forbici F; Ceccherini-Silberstein F; Gori C; D'Arrigo R; Trotta MP; Narciso P; Perno CF; Antinori A;
    Infection; 2009 Jun; 37(3):203-9. PubMed ID: 19274429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
    Palich R; Wirden M; Peytavin G; Lê MP; Seang S; Abdi B; Schneider L; Tubiana R; Valantin MA; Paccoud O; Soulié C; Calvez V; Katlama C; Marcelin AG
    J Antimicrob Chemother; 2020 Oct; 75(10):2981-2985. PubMed ID: 32642769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?
    Poveda E; Crespo M
    AIDS Rev; 2018; 20(1):71-72. PubMed ID: 29628513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.